Stock Earnings

Question 1

What are ARS Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), ARS Pharmaceuticals Inc has a total asset of $327, Net loss of $-171

Question 2

What are the key financial ratios for SPRY?

Accepted Answer

ARS Pharmaceuticals Inc's Current ratio is 1.53, has a Net margin is -203.57, sales per share of $0.85.

Question 3

How is ARS Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

ARS Pharmaceuticals Inc largest revenue segment is Needle-free Intranasal, at a revenue of 30,000 in the most earnings release.For geography, United States is the primary market for ARS Pharmaceuticals Inc, at a revenue of 30,000.

Question 4

Is ARS Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, ARS Pharmaceuticals Inc has a net loss of $-171

Question 5

Does ARS Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, ARS Pharmaceuticals Inc has liability of 213

Question 6

How many outstanding shares for ARS Pharmaceuticals Inc?

Accepted Answer

ARS Pharmaceuticals Inc has a total outstanding shares of 99.29

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	116	84	89	0	1	0
Revenue Growth (YoY)	4%	-6%	--	-100%	--	--
Cost of Revenue	33	19	0	--	--	--
Gross Profit	83	64	88	--	--	--
Selling, General & Admin	284	230	71	47	18	28
Research & Development	15	13	19	20	18	61
Operating Expenses	299	244	91	67	36	89
Other Non Operating Income (Expenses)	8	10	11	13	1	--
Pretax Income	-215	-171	8	-54	-34	-89
Income Tax Expense	--	0	0	--	--	--
Net Income	-215	-171	7	-54	-34	-89
Net Income Growth	348%	-2,543%	-112.99%	59%	-62%	178%
Shares Outstanding (Diluted)	99.31	98.56	102.39	95.21	39.96	34.93
Shares Change (YoY)	1%	-4%	8%	138%	14%	1%
EPS (Diluted)	-2.17	-1.73	0.07	-0.57	-0.87	-2.56
EPS Growth	353%	-2,325%	-113.99%	-34%	-66%	169%
Free Cash Flow	-196	-171	12	-59	-40	-68
Free Cash Flow Per Share	-1.97	-1.73	0.11	-0.61	-1	-1.94
Gross Margin	71.55%	76.19%	98.87%	--	--	--
Operating Margin	-186.2%	-213.09%	-3.37%	0%	-3,500%	0%
Profit Margin	-185.34%	-203.57%	7.86%	0%	-3,400%	0%
Free Cash Flow Margin	-168.96%	-203.57%	13.48%	0%	-4,000%	0%
EBITDA	-215	-179	-3	-67	-35	-89
EBITDA Margin	-185.34%	-213.09%	-3.37%	0%	-3,500%	0%
D&A For EBITDA	1	0	0	0	0	0
EBIT	-216	-179	-3	-67	-35	-89
EBIT Margin	-186.2%	-213.09%	-3.37%	0%	-3,500%	0%
Effective Tax Rate	--	0%	0%	--	--	--

ARS Pharmaceuticals Inc (SPRY) Price

SPRY Stock Price Chart

SPRY Income

Follow-Up Questions